These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3432286)

  • 1. The role of reactive metabolites in drug-induced teratogenesis.
    Hales BF; Slott VL
    Prog Clin Biol Res; 1987; 253():181-91. PubMed ID: 3432286
    [No Abstract]   [Full Text] [Related]  

  • 2. Teratogenicity of cyclophosphamide metabolites: phosphoramide mustard, acrolein, and 4-ketocyclophosphamide in rat embryos cultured in vitro.
    Mirkes PE; Fantel AG; Greenaway JC; Shepard TH
    Toxicol Appl Pharmacol; 1981 Apr; 58(2):322-30. PubMed ID: 7245204
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
    Hales BF
    Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
    Hales BF
    Cancer Res; 1982 Aug; 42(8):3016-21. PubMed ID: 7046914
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of 4-hydroperoxycyclophosphamide (4-OOH-CP) and 4-hydroperoxydechlorocyclophosphamide (4-OOH-deCICP) on the cell cycle of post implantation rat embryos.
    Little SA; Mirkes PE
    Teratology; 1992 Feb; 45(2):163-73. PubMed ID: 1615426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the embryotoxicity of acrolein, but not phosphoramide mustard, by glutathione depletion in rat embryos in vitro.
    Slott VL; Hales BF
    Biochem Pharmacol; 1987 Jun; 36(12):2019-25. PubMed ID: 3593406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of DNA damage and embryotoxicity induced by 4-hydroperoxydechlorocyclophosphamide in postimplantation rat embryos.
    Little SA; Mirkes PE
    Teratology; 1990 Feb; 41(2):223-31. PubMed ID: 2321166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitro.
    Mirkes PE; Greenaway JC; Rogers JG; Brundrett RB
    Toxicol Appl Pharmacol; 1984 Feb; 72(2):281-91. PubMed ID: 6546458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oxygen concentration on the teratogenicity of salicylate, niridazole, cyclophosphamide, and phosphoramide mustard in rat embryos in vitro.
    Greenaway JC; Mirkes PE; Walker EA; Juchau MR; Shepard TH; Fantel AG
    Teratology; 1985 Oct; 32(2):287-95. PubMed ID: 4049287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological and biochemical aspects of monofunctional phosphoramide mustard teratogenicity in rat embryos cultured in vitro.
    Mirkes PE; Greenaway JC; Hilton J; Brundrett R
    Teratology; 1985 Oct; 32(2):241-9. PubMed ID: 4049282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the cyclophosphamide metabolite acrolein in mammalian limb bud cultures.
    Stahlmann R; Bluth U; Neubert D
    Arch Toxicol; 1985 Aug; 57(3):163-7. PubMed ID: 3933456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the teratogenic potential of acrolein and cyclophosphamide in a rat embryo culture system.
    Schmid BP; Goulding E; Kitchin K; Sanyal MK
    Toxicology; 1981; 22(3):235-43. PubMed ID: 7340013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of metabolites of cyclophosphamide in cardiotoxicity.
    Kurauchi K; Nishikawa T; Miyahara E; Okamoto Y; Kawano Y
    BMC Res Notes; 2017 Aug; 10(1):406. PubMed ID: 28807058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
    Crook TR; Souhami RL; McLean AE
    Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratology testing: I. Development and status of short-term prescreens. II. Biotransformation of teratogens as studied in whole embryo culture.
    Shepard TH; Fantel AG; Mirkes PE; Greenaway JC; Faustman-Watts E; Campbell M; Juchau MR
    Prog Clin Biol Res; 1983; 135():147-64. PubMed ID: 6364154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK; Waxman DJ
    Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
    Spielmann H; Jacob-Müller U
    Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The embryolethality and teratogenicity of acrolein in cultured rat embryos.
    Slott VL; Hales BF
    Teratology; 1986 Oct; 34(2):155-63. PubMed ID: 3775668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro.
    Chen B; Cyr DG; Hales BF
    Teratology; 1994 Jul; 50(1):1-12. PubMed ID: 7974249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.